TKVAdelisted

Salspera, Inc.

Healthcare·Oncology·Phase 2
Oncology

Salspera, Inc. (TKVA): 2 pipeline candidates · 1 clinical trial. Updated within the last hour.

5.3/10

BioSniper Score

2-factor signal · derived from public data

Cash RunwayN/A

N/A

Financial HealthN/A

N/A

Pipeline Maturity6.0

Lead: Phase 2

Pipeline Breadth4.6

2 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for Salspera, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Pipeline (2 candidates)

DrugPhase
folfirinox alonePhase 2
salmonella-il2Phase 2
1 clinical trial

Frequently asked questions

How many drug candidates are in Salspera, Inc.'s pipeline?

Salspera, Inc. (TKVA) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is Salspera, Inc.'s lead drug candidate?

Salspera, Inc.'s most advanced tracked candidate is folfirinox alone (Phase 2) for Metastatic Pancreatic Cancer.

Get the full picture on Salspera, Inc.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.

Start Free AnalysisBrowse Calendar